Biotechnology and bioengineering – Page 16
-
BusinessExpanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
-
BusinessPacBio sues Oxford Nanopore for patent infringement
Firms spar over single-molecule gene sequencing technology
-
OpinionSafety first with gene editing
Why Darpa is creating a biosafety and biosecurity toolkit for genome editors
-
ResearchFive new artificial yeast chromosomes made
The artificial yeast genome is now around a third complete
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
FeatureDeal or no deal?
Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions
-
BusinessUS biotech leaders protest immigration ban
Donald Trump’s suspended order would endanger America’s biotech industry if re-instated
-
BusinessCholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
ResearchStrongest synthetic spider silk spun-out in the lab
Mimicking spiders’ spinning glands could cut cost of synthetic silk
-
NewsFears that gene-editing cancer trials are premature
Warnings from geneticists that Crispr trial failures could knock promising technique’s prospects
-
ResearchLow phosphorus rice offers fertiliser pollution solution
Silencing gene that directs phosphorus into rice grains could mean cheaper food and healthier rivers
-
ResearchBiocompatible hydrogel focuses on lenses
A bioinspired smart material that swells and contracts could be used to make optical lenses
-
ResearchProtective polymer coats 'grown' on cells
Coated cells could be harnessed for biomedical applications
-
ResearchDesigner carbon dioxide-consuming organisms on cards
Rational design creates cycle that’s faster than the natural carbon-fixing process used by plants
-
OpinionRegulatory tightropes
When lobbying and marketing clash with scientific evidence, regulators walk a fine line
-
BusinessCorn growers’ lawsuit contested by Syngenta
Syngenta opposes class action seeking over $5bn in damages related to its genetically engineered corn
-
FeatureSmarter smells
After years of research, the flavour and fragrance industry is increasingly turning to biotechnology for commercial production, as Emma Davies reports
-
ResearchDNA suitcases packed with gene therapy cargo
Nano-sized capsules can be unlocked to release drugs on demand
-
ResearchPlastics synthesis goes green
Enzyme-catalysed polymerisation could lead to sustainable plastics
-
ResearchNanoplasters get cells into sticky situation
Nanoparticles that glue cells together could aid wound healing or stop tumour metastasis